Arimidex Oral Tablet 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Arimidex: Oral tablet (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1149.JPG
Arimidex 1mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: A  |  Adx 1
Drug Image file DrugItem_1149.JPG
Arimidex 1mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: A  |  Adx 1

What is this Medicine?

ANASTROZOLE (an AS troe zole) is used to treat breast cancer in women who have gone through menopause. Some types of breast cancer depend on estrogen to grow, and this medicine can stop tumor growth by blocking estrogen production.

Similar Generic Drugs : Anastrozole: Oral tablet (1mg)
CVS Pharmacy Patient Statistics for Arimidex: Oral tablet(1mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Arimidex 1mg Tablet

NDC: 003100201
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer

Sometimes used for but not FDA approved for the following conditions:
Uterine Leiomyomata, Endometriosis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Arimidex 1mg Tablet
Drug Image file DrugItem_10703.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: A  |  Adx 1
Shape: round
Color: white
Drug Image file DrugItem_1149.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: A  |  Adx 1
Shape: round
Color: white

Reported Side Effects for Arimidex 1mg Tablet

High Calcium Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot In Eye Incidence:
<4.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
<4.0%*
Severity: SEVERE
Onset: DELAYED
Skin Ulcer Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<0.1%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
0.9-1.2%*
Severity: SEVERE
Onset: DELAYED
Tiredness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Vaginal Irritation Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Vaginal Bleeding Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
2.0-9.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
2.0-7.0%*
Severity: MILD
Onset: DELAYED
Blood Clot Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
2.0-4.0%*
Severity: SEVERE
Onset: DELAYED
Rhinitis Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: RAPID
Paresthesias Incidence:
2.0-7.0%*
Severity: MILD
Onset: DELAYED
Brain Attack Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Feeling Sick Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Vaginal Discharge Incidence:
2.0-3.0%*
Severity: MILD
Onset: DELAYED
Confusion Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0-6.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
2.0-6.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
2.0-5.0%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
2.0-6.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
2.0-13.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
2.0-15.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
2.0-13.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
2.3-11.6%*
Severity: MODERATE
Onset: EARLY
Wrist Nerve Pain Incidence:
2.5%*
Severity: MILD
Onset: DELAYED
Excessive Mucle Tone Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Discharge Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Vaginal Infection Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Pelvic Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
5.0-8.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
5.0-8.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
5.0-7.0%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
6.0-11.0%*
Severity: MILD
Onset: EARLY
Bone Pain Incidence:
6.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
6.0-9.0%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
7.0-18.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
7.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
7.0-9.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
7.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
8.0-13.0%*
Severity: MILD
Onset: EARLY
High Cholesterol Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Broken Bones Incidence:
10.0%*
Severity: SEVERE
Onset: DELAYED
Back Pain Incidence:
10.0-12.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
11.0-20.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
11.0-36.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
13.0-19.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
19.0%*
Severity: MILD
Onset: EARLY
Peripheral Vasodilation Incidence:
25.0-36.0%*
Severity: MODERATE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Arimidex

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5